You are here:-Tag: oncology

Stars Seek Alternative Treatments – NY Daily News November 2009

"More than 30 percent of cancer patients will try some kind of alternative therapy," says Dr. Roberta Lee, vice chair of the Department of Integrative Medicine at Beth Israel Medical Center and medical director of the Continuum Center for Health and Healing. "As at treatment on its own, alternative therapy is complicated and risky. But when it is supportive, it is a good strategy."

Biography of Dr. Isaac Eliaz –

Dr. Isaac Eliaz, a pioneer in the field of integrative medicine since the early 1980s, is a respected author, lecturer, researcher, product formulator and clinical practitioner. Since 1991, Dr. Eliaz has maintained a busy private practice in northern California that focuses primarily on integrative, holistic protocols for cancer patients. He leads an integrative medical team at Amitabha Clinic in Sebastopol, California with focus on cancer and other chronic ailments.

Timely News for Breast Cancer Awareness Month!

Botanical Formula Delivers Powerful Support for Breast Health Read Dr. Eliaz’s article published the October 2012 issue of the Nutraceutical Business & Technology Journal, reprinted here for our readers: Not long ago, there was a stark dividing line between pharmaceutical drugs and nutritional supplements. The perception was that pharmaceuticals are intensely researched (which they are) and

New Hope for Deadly Cancer

In my own clinical practice, I have seen remarkable results with breast cancer patients using a combination of targeted botanicals and integrative approaches. My practice of patient-driven medicine and the results I witnessed using powerful combinations of natural ingredients were the driving force behind the years of work and research...

Breakthrough Cancer Research Presented at Naturopathic Oncology Conference

Carefree, Ariz., (March 6, 2012) -- Isaac Eliaz, M.D., M.S., L.Ac., distinguished medical doctor and researcher, presents Galectin-3 as a breakthrough biomarker for numerous life-threatening diseases. He also shared new research on the critical role of Modified Citrus Pectin (MCP) as the foremost Galectin-3 blocker. Dr. Eliaz's latest presentation was given to hundreds of integrative oncologists during the Oncology Association of Naturopathic Physician's 2012 Convention (OncANP).